Kühnl A - Search Results

1

High expression of IGFBP2 is associated with chemoresistance in adult acute myeloid leukemia.

Kühnl A, Kaiser M, Neumann M, Fransecky L, Heesch S, Radmacher M, Marcucci G, Bloomfield CD, Hofmann WK, Thiel E, Baldus CD. Kühnl A, et al. Leuk Res. 2011 Dec;35(12):1585-90. doi: 10.1016/j.leukres.2011.08.006. Epub 2011 Sep 6. Leuk Res. 2011. PMID: 21899885 Free PMC article.

2

High BAALC expression predicts chemoresistance in adult B-precursor acute lymphoblastic leukemia.

Kühnl A, Gökbuget N, Stroux A, Burmeister T, Neumann M, Heesch S, Haferlach T, Hoelzer D, Hofmann WK, Thiel E, Baldus CD. Kühnl A, et al. Blood. 2010 May 6;115(18):3737-44. doi: 10.1182/blood-2009-09-241943. Epub 2010 Jan 11. Blood. 2010. PMID: 20065290 Free article.

3

BAALC-associated gene expression profiles define IGFBP7 as a novel molecular marker in acute leukemia.

Heesch S, Schlee C, Neumann M, Stroux A, Kühnl A, Schwartz S, Haferlach T, Goekbuget N, Hoelzer D, Thiel E, Hofmann WK, Baldus CD. Heesch S, et al. Among authors: kuhnl a. Leukemia. 2010 Aug;24(8):1429-36. doi: 10.1038/leu.2010.130. Epub 2010 Jun 10. Leukemia. 2010. PMID: 20535151

4

The role of microRNA-196a and microRNA-196b as ERG regulators in acute myeloid leukemia and acute T-lymphoblastic leukemia.

Coskun E, von der Heide EK, Schlee C, Kühnl A, Gökbuget N, Hoelzer D, Hofmann WK, Thiel E, Baldus CD. Coskun E, et al. Among authors: kuhnl a. Leuk Res. 2011 Feb;35(2):208-13. doi: 10.1016/j.leukres.2010.05.007. Epub 2010 Jun 8. Leuk Res. 2011. PMID: 20570349

5

Overexpression of LEF1 predicts unfavorable outcome in adult patients with B-precursor acute lymphoblastic leukemia.

Kühnl A, Gökbuget N, Kaiser M, Schlee C, Stroux A, Burmeister T, Mochmann LH, Hoelzer D, Hofmann WK, Thiel E, Baldus CD. Kühnl A, et al. Blood. 2011 Dec 8;118(24):6362-7. doi: 10.1182/blood-2011-04-350850. Epub 2011 Oct 18. Blood. 2011. PMID: 22010100 Free article. Clinical Trial.

6

Antileukemic activity of the HSP70 inhibitor pifithrin-μ in acute leukemia.

Kaiser M, Kühnl A, Reins J, Fischer S, Ortiz-Tanchez J, Schlee C, Mochmann LH, Heesch S, Benlasfer O, Hofmann WK, Thiel E, Baldus CD. Kaiser M, et al. Among authors: kuhnl a. Blood Cancer J. 2011 Jul;1(7):e28. doi: 10.1038/bcj.2011.28. Epub 2011 Jul 15. Blood Cancer J. 2011. PMID: 22829184 Free PMC article.

7

Downregulation of the Wnt inhibitor CXXC5 predicts a better prognosis in acute myeloid leukemia.

Kühnl A, Valk PJ, Sanders MA, Ivey A, Hills RK, Mills KI, Gale RE, Kaiser MF, Dillon R, Joannides M, Gilkes A, Haferlach T, Schnittger S, Duprez E, Linch DC, Delwel R, Löwenberg B, Baldus CD, Solomon E, Burnett AK, Grimwade D. Kühnl A, et al. Blood. 2015 May 7;125(19):2985-94. doi: 10.1182/blood-2014-12-613703. Epub 2015 Mar 24. Blood. 2015. PMID: 25805812 Free PMC article.

8

Anti-tumor effect of honokiol alone and in combination with other anti-cancer agents in breast cancer.

Liu H, Zang C, Emde A, Planas-Silva MD, Rosche M, Kühnl A, Schulz CO, Elstner E, Possinger K, Eucker J. Liu H, et al. Among authors: kuhnl a. Eur J Pharmacol. 2008 Sep 4;591(1-3):43-51. doi: 10.1016/j.ejphar.2008.06.026. Epub 2008 Jun 12. Eur J Pharmacol. 2008. PMID: 18588872

9

Molecular markers in acute myeloid leukaemia.

Kühnl A, Grimwade D. Kühnl A, et al. Int J Hematol. 2012 Aug;96(2):153-63. doi: 10.1007/s12185-012-1123-9. Epub 2012 Jul 13. Int J Hematol. 2012. PMID: 22791509 Review.

10

[Systemic therapy of male breast cancer].

Eucker J, Kühnl A, Possinger K. Eucker J, et al. Among authors: kuhnl a. Zentralbl Chir. 2007 Oct;132(5):396-9. doi: 10.1055/s-2007-981267. Zentralbl Chir. 2007. PMID: 17907081 German.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

72 results

Search Page